Topline Phase 3 results show Eli Lilly’s retatrutide beat Novo’s Ozempic on measures of blood sugar and weight loss in adults ...

Artiva Biotherapeutics attributed one of the fatalities to a drug used to prepare patients for cell therapy and not to the ...

Roughly 31,000 Kaiser Permanente nurses and other healthcare workers returned to work on Tuesday following a four-week strike. The strike ended because there has been significant movement at the ...

The cost of waiting is not evenly distributed. Rural and critical access hospitals report under 50 percent adoption of even ...

Corxel Pharmaceuticals is catching up to others with oral GLP-1 obesity drugs, but the biotech claims its small molecule ...

Gilead Sciences is getting global rights to an experimental PepStar Therapeutics oral peptide designed to inhibit the IL-23 ...

Fractyl Health reported positive six-month trial results from an investigation of its Revita procedure last week, but shares ...

Sutter Health, a nonprofit healthcare system based in Sacramento, California, is expanding its digital chronic disease management program, Sutter Sync, to include patients with heart failure. The ...

OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved ...

CareValidate expanded its HRT offering for telehealth companies, combining hormone therapy with provider access, pharmacy ...

In this month’s episode, Senior Reporter Katie Adams discussed some executive hires, promotions and departures that recently occurred in the healthcare world, as well as layoffs affecting the industry ...

MedTech Conference panelists cited inflammation research, listening to women, clinical trial representation and investment as ...